Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta Group Plc LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.75p -2.63% 27.75p 27.00p 28.50p 28.50p 27.75p 28.50p 151,875 16:24:03
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.8 -10.4 -13.5 - 32.18

Avacta Share Discussion Threads

Showing 4776 to 4799 of 4800 messages
Chat Pages: 192  191  190  189  188  187  186  185  184  183  182  181  Older
DateSubjectAuthorDiscuss
15/5/2019
11:00
When Avacta's Market Cap was around 50 million plus. Alistair Smith was inferring that the reagents side of the bussiness was worth around that alone!? Well the reagents figures in the last disclosure were poor. So that is not much comfort as a fall back position. We need a solid deal soon. Otherwise the story is not sustainable. IMHO
lantanatony
15/5/2019
07:34
With a market cap of £30m, and the LG deal alone worth potentially $300m, then the potential upside is clearly enormous... but until proven, it remains just that - potential upside. They have to get new deals and manage cash for us to receive the full rewards as and when.
the drewster
15/5/2019
01:58
We have a platform not a single drug. It's based on a human protein. We have the reagent side of the business which is perceived less risky. And there is the veterinary side of the business also. Ok the last point might be considered a side show but its part of the business nonetheless.
danatkins
15/5/2019
01:48
Found this interesting hxxps://www.sickeconomics.com/2019/01/28/signs-sell-biotech-stock/
danatkins
14/5/2019
22:24
Amazing what a stock can do , considering the company's research and licence deal and as indicated further deals to be announced.One announcement would put 15% on the stock immediately and off course let us speculate that a further deal was to be announced.New Executive from Hoffman la Roche,ASCO coming upI would pick up stock at these levels and enjoy the ride up to the mid 40' once further news flow is out.
daymer58
13/5/2019
13:05
Currently trend is down. The 200ma on daily is keeping us back. We are coming into a gap zone. The not so clever pi will run for the exit for a loss. Market will test the nerves of PIs. Ask yourself why you invested and remain objective. The down side is limited from here but can go lower. I'm here for the long haul so ignore the fun and games being played
danatkins
13/5/2019
12:26
I would think we are close to the bottom The RSI was at 30 at the weekend it has bounced off 30 a good few times5 or 6 straight buys and the pent up herd buying will begin
basem1
13/5/2019
11:15
If they can prove safety within the deadline they've given then cash may last until results. However that is cutting it. It all about the tech so any positive outcomes to reinforce that then cash will be forthcoming. Yes more dilution but we know that. I'm I happy re share price shxt no. Is it the end hell no. But some news here would be good. Just for reflection amazon went to under 5 bucks ok that was the dot com crash period. Same year amzn went up 1000%. This is about the tech not the investors that sell on lows
danatkins
11/5/2019
09:01
If (and therein lies the challenge) they prove the platform in human patients, this will seriously multibag, how long that takes and how much cash is the risk.
the drewster
11/5/2019
08:54
Expenses keep going up. The story has been the same for the last ten years. It is always going to happen in the next two years and it never has.
poacher45
10/5/2019
13:30
ThxWith ASCO coming up as well, news flow will pick upVery oversold
daymer58
10/5/2019
10:04
Latest interview with DirectorsTalk - http://bit.ly/2Hbsp1G
astonedt
07/5/2019
12:41
Agree re don't sell and wait it out games being played. Very low volume. If you believe in the tech then hold and add if you feel comfortable. The share price and the tech are not the same. I invested because I believe in the tech not of share price. Weak hands will get flushed out
danatkins
07/5/2019
12:13
Very disappointing. One thing for sure im not selling. When the share price Of these exciting companies are suggestive of ‘long term’, i do just that i lock em away. No way will i take a loss on this one. 5 years 10 years ill still be here. So play your game mr market, you dont fool me into selling.
escapetohome
07/5/2019
10:37
IndeedWe have their partner Moderna hosting a science day and reporting number today and tomorrowTheir sector is very hotUS valuations would triple the share priceThey have new Korean partner with up front payments and talking to others.A screaming buy
daymer58
07/5/2019
10:15
Hmmm what's happening here... not long ago this was near 50p.Another few pence off and this will have lost 50% in value.
losses
07/5/2019
09:54
Between here and 20
toffeeman
07/5/2019
09:46
With little or no support for the Avacta share price in this in this "Very exciting year". Where is the bottom?
lantanatony
01/5/2019
14:32
View Avacta Group's talk at The Global Group UK Investor Show: https://www.ukinvestorshow.com/videos/avacta-group-plc/
leeroy jenkins
16/4/2019
09:39
CEO Q&A discussing the development partnership and license agreement with LG Chem, in-house drug development and the collaborations with Moderna & Tufts - http://bit.ly/2v3Ib9k
astonedt
15/4/2019
16:45
Sweet and sour!
lantanatony
15/4/2019
16:28
Mouldy maybe. But sweet jam all the same.
escapetohome
15/4/2019
14:50
Killieboy The jam is getting very mouldy and it sees nobody wants it! Not surprised when you see the numbers. It now seems that the next LG "NEAR TERM " revenue could be as far away as another 18 months. After the next funding round then? Also no option payment from Modera.why?
lantanatony
10/4/2019
14:09
Just to remind everybody Moderna is presenting today at the Needham conference
hampton58
Chat Pages: 192  191  190  189  188  187  186  185  184  183  182  181  Older
Your Recent History
LSE
AVCT
Avacta
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190519 17:33:35